硬化剂“双针法”介入注射治疗儿童体表静脉畸形的临床治疗研究

Clinical treatment of percutaneous interventional injecting sclerosing agent by double needle to treat childhood superficial venous malformations

目的:分析和探讨采取硬化剂"双针法"介入注射治疗儿童体表静脉畸形的临床疗效。方法:回顾性分析41例静脉畸形患者采取"双针法"介入注射硬化剂治疗的临床资料。治疗前超声评估畸形静脉腔的体积,疗程结束后第6个月观察临床疗效及超声评估畸形静脉腔的体积缩小情况,同时观察术后近期及远期并发症,如肺栓塞、皮肤溃疡、局部肿胀、发热等。结果:所有患者在疗程结束后6个月时随访发现,治疗后畸形静脉腔的体积均较治疗前明显缩小,治疗均未出现严重不良并发症。结论:采取"双针法"硬化剂注射治疗儿童体表静脉畸形安全可靠,疗效确切,不良反应小,值得推广。

Objective：To analyze and discuss the clinical treatment of percutaneous interventional injecting sclerosing agent by double needle to treat childhood superficial venous malformations. Methods：Clinical data of 41 venous malformation cases were collected. The volume of venous malformation was detected by ultrasound before treatment, and clinical efficacy and deformed venous contractible volume was appraised 6 months after therapy session. Postoperative complications such as pulmonary embolism, skin ulcer, local swelling and fever were observed. Results：All patients received a complete therapy session, and were followed up after 6 months. The volume of venous malformation were significantly decreased after treatment （ P 〈 0.01 ）. No adverse effects and severe complications were observed. Conclusion ： The way of percutaneous interventional injecting sclerosing agent by double needle to treat childhood superficial venous malformations was worth spreading with reliable efficacy, safety and less incident of adverse effects.